New technology improves malaria control and vaccine development
Professor Ivo Mueller was part of a research team that developed a new molecular technology which will improve evaluation of malaria control methods and vaccine development.
A new technique that accurately determines the risk of infants in endemic countries developing clinical malaria could provide a valuable tool for evaluating new malaria prevention strategies and vaccines.
The technique could even help to understand how anti-malarial vaccine and treatment strategies act to reduce malaria, say researchers from the Walter and Eliza Hall Institute, Swiss Tropical and Public Health Institute, University of Basel and the Papua New Guinea Institute of Medical Research.
Professor Ivo Mueller from the Walter and Eliza Hall Institute said the research team discovered that the number of new malaria parasites that infants acquire over time is strongly linked to the risk that the child will develop clinical disease.
"It was very clear that infection with new and genetically different malaria parasites was the single biggest factor in determining the risk of an infant becoming sick from malaria, more than any other factor including age, the use of bed nets or the risk of transmission in the area. We were actually surprised by how clear the correlation was," Professor Mueller said.
The molecular technique to genetically differentiate Plasmodium falciparum parasites was developed by Dr Ingrid Felger at the Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Switzerland. Professor Terry Speed from the Walter and Eliza Hall Institute's Bioinformatics division helped to develop mathematical algorithms to process the data.
Dr Felger said the researchers used high-throughput screening to determine the number of genetically-distinct Plasmodium falciparum malaria parasites that acquired by Papua New Guinean children aged one to four over a period of 16 months. The research was published today in the journal Proceedings of the National Academy of Sciences.
"This new research tool is elegantly simple but very powerful, and easily applicable in many circumstances, without a high level of technology or training," Dr Felger said. "We think it could have profound applications. This technology will be particularly useful for assessing ideal vaccine candidates for preventing malaria, help to develop better ways of performing future human trials of new potential malaria vaccines, and identifying the mechanism of action for existing vaccines and treatments."
Each year more than 250 million people worldwide contract malaria, and up to one million people die. Malaria is particularly dangerous for children under five and pregnant women. Plasmodium falciparum is the most lethal of the four Plasmodium species, and is responsible for most clinical disease.
Professor Mueller said the technology is already being used in the field, recently helping to explain why people with sickle-cell anaemia are less at risk of malaria infection. He said that accurately assessing the burden of malaria parasites acquired by children in countries where the disease is endemic is invaluable.
"One of our biggest problems in developing useful vaccines, treatments and preventative strategies for malaria is reliably predicting the distribution and risk of malaria at an individual level. There is huge variation in the risk of developing clinical malaria within a community or village, or within a particular age group, and we now have an accurate way to measure this," Professor Mueller said.
More information: www.pnas.org/conte… 109.abstract
Journal reference: Proceedings of the National Academy of Sciences
Provided by Walter and Eliza Hall Institute
- Combination drug treatment can cut malaria by 30 percent Apr 02, 2012 | not rated yet | 0
- Promising candidates for malaria vaccine revealed Jan 18, 2010 | not rated yet | 0
- 'Protein microarrays' may reveal new weapons against malaria Nov 01, 2011 | not rated yet | 0
- First genetically-engineered malaria vaccine to enter human trials Jul 28, 2009 | not rated yet | 0
- Unveiling malaria's 'invisibility cloak' Jan 18, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
A new coronavirus has now claimed 22 lives worldwide out of 44 lab-confirmed cases, mostly in Saudi Arabia, World Health Organization officials said Thursday.
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0
A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...
Diseases, Conditions, Syndromes 3 hours ago | not rated yet | 0 |
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
Diseases, Conditions, Syndromes 21 hours ago | not rated yet | 0
The World Health Organization says the Horn of Africa is experiencing an outbreak of polio with cases confirmed in Kenya and Somalia.
Diseases, Conditions, Syndromes 22 hours ago | not rated yet | 0
A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.
Diseases, Conditions, Syndromes 22 hours ago | not rated yet | 0
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
58 minutes ago | not rated yet | 0 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of ...
33 minutes ago | 5 / 5 (1) | 0 |
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
32 minutes ago | not rated yet | 0 |
(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.
49 minutes ago | not rated yet | 0 |
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
26 minutes ago | not rated yet | 0 |
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
33 minutes ago | not rated yet | 0 |